Both isolated PPNAD and CNC have been associated with inactivating mutations in PRKAR1A, the gene encoding the type 1α regulatory subunit (R1α) of the cAMP-dependent protein kinase (PKA) [2], [3]. This evidence concerns the gene PRKAR1A and primary pigmented nodular adrenocortical disease.